2020

May

Cost-Effective       Method to Measure Fetal Fraction by Adaptive Multiple Regression Techniques with Optimally Selected Autosomal Chromosome Regions(Paper Published IEEE)

Running Projects 2020

2019

Dec

New-born screening by

research & study MOU

with Big-data center AI team (Sejong University)

Nov.

Liquid Biopsy Cancer Screening research & study

MOU

(Yonsei University Hospital)

Oct.

Genetic Test Laboratory Qualified "A" grade obtained

(upgraded for 2020)

Jun.

Premature birth prediction system development MOU

(Hanlim University Hospital)

Jan.

Moved-in to Newly Integrated Lab & Office

(Gwanggyo Central Biz Tower)

2018

Aug.

NIPT patent 3rd stage approval by KIPO

Jul.

NIPT Tech-Transfer to major hospitals in Korea

(CHA / JEIL Hospitals)

 

International NIPT patent registered in US

May

GenoBro(PGS) Test Launch

iGenomics genetic test

Licensing-in (ERA,EMMA)

Apr.

1st NGS-PGS Test approval in S.Korea (KCDC)

Jan.

NIPT Tech-Transfer contract in Middle-East countries

2017

May

NIPT patent 2nd stage approval by KIPO

Feb.

GenoMom service contract with PTC in Thailand

2016

Oct.

Published 3rd Clinical Report in SCI-class journal

(BMC Medical Genomics)

Apr.

Published 2nd Clinical Report in SCI-class journal

(BMC Medical Genomics)

NIPT patent registered in KIPO

Jan.

Genetic Test Laboratory approved by KCDC

2015

Nov.

Clinical Laboratory Set-up

Sep.

GenoMom(NIPT) test launch

GenomomTM registered

May

Office move to Gwanggyo

2014

Oct.

Published 1st Clinical Report in SCI-class journal

(PLOS ONE)

2012

Nov.

Company established

810 Gwanggyo Central Biz Tower, Suwon-si, Gyeonggi-do, Republic of Korea   e-mail : info@genomecare.net

©2020 by THERAGEN GENOMECARE.

All rights reserved.